FDA Begins Publishing Complete Response Letters for Ongoing Drug Applications in Real Time on September 11, 2025 Application procedure drug applications openFDA public health medicine (field) radical transparency real-time disclosure regulatory transparency Response Letters United States Food and Drug Administration +
FDA Releases Second Batch of Complete Response Letters, Moves to Real-Time Public Disclosure on September 05, 2025 Complete CRLs Drug Approval real-time publishing regulatory disclosure Response Letters Translucent United States Food and Drug Administration +